I think your assertion is true. So far the stock is generally holding around the $8 level save a couple sells here and there. Someone still buying it back to $8 .... thus far. Given the tightly held nature of the stock I think that is a good sign that Payne is still working a pharma deal. Externally no reason for an outsider to buy it. No news. No info.
So we wait on the other shoe to drop. And like you ... I'm watching for clues as to the stock movement. The way these low floaters are popping off these days ..... a pharma deal from ZIVO could send this northward big time on release. Of course I would expect ZIVO to botch or blunt the release of that info as they always do ... if it happens of course. Remember that this is a novel approach for animal pharma. No change in this space for 6 decades. So a deal as we see not happening overnight. Encouraged by recent Maggiore buy and the stock generally maintianing level .........leads me to think things are still being worked given it's timing and the action.
Market Data 
Markets 
AI
